Kaia Health announces that it is the first and (currently only) MSK digital therapy, and the second digital health company in history, to receive Program Validation, the Validation Institute’s highest level of validation. The validation recognizes Kaia Health’s rigorous, evidence-based digital therapy approach to treating musculoskeletal conditions that led to its best-in-class financial and health outcomes.

  • Kaia’s members saw significant pain reduction (33% after 3 month)
  • Overall improvement in both their mental and physical health
  • Up to 80% reduction in inpatient cost compared to traditional methods of treatment.

Kaia’s unique physical therapy-inspired program offers members personalized and self-directed care anytime, anywhere through a digital app and care team. With just the camera on the phone, Kaia’s advanced motion analysis technology provides real-time corrective feedback on body movements, eliminating the need for sensors.

The Validation Institute is a non-profit organization established to drive transparency in the marketplace by providing unbiased, data-driven insights on health care solutions. “The clinical results we found with Kaia Health are remarkable – and we are thrilled to recognize the important work they are doing in the digital health space,” said Benny DiCecca, CEO, Validation Institute.

“With Kaia, we have identified an MSK solution that is steeped in scientific rigor we rarely find in digital health. For anyone evaluating an MSK solution, Kaia would be an excellent choice,” said Al Lewis, Quizzify CEO and Validation Institute Advisor.

Over time, Validation Institute has shifted from only affirming specific financial and health improvement claims to now assessing healthcare solutions’ programs as a whole. To qualify for the highest level of validation, vendors must prove clinical rigor using gold standard evaluation methodologies, including the ‘parallel assignment method’ used by Kaia Health. The Program Validation carries a $50K guarantee that Kaia Health delivers on health and financial outcomes outlined in previous validation reports.

MSK conditions affect 1 in 2 adults in the U.S. and there are numerous solutions out there making big claims on outcomes with no substantiation. “Clinical excellence has always been at the core of what we do,’ said Nigel Ohrenstein, president of Kaia Health, ‘We are proud to receive this recognition as clinical excellence must be the standard for all digital health companies.” Kaia Health is the only MSK company to have completed a true Randomized Control Trial (RCT), and with 11 clinical trials to date, has completed significantly more research than any other digital MSK solution.

[Source(s): Kaia Health, Business Wire]